[
    [
        {
            "time": "",
            "original_text": "渝股中考成绩单：29只股飘红，医药股成明星，这三股股价翻倍了",
            "features": {
                "keywords": [
                    "渝股",
                    "中考成绩单",
                    "飘红",
                    "医药股",
                    "明星",
                    "股价翻倍"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "渝股中考成绩单：29只股飘红，医药股成明星，这三股股价翻倍了",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "智飞生物：合作研发的重组新型冠状病毒疫苗（CHO细胞）目前正在开展Ⅰ期临床试验",
            "features": {
                "keywords": [
                    "智飞生物",
                    "合作研发",
                    "重组新型冠状病毒疫苗",
                    "CHO细胞",
                    "Ⅰ期临床试验"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：合作研发的重组新型冠状病毒疫苗（CHO细胞）目前正在开展Ⅰ期临床试验",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药股“霸屏” A股上半年牛熊榜放榜",
            "features": {
                "keywords": [
                    "医药股",
                    "霸屏",
                    "A股",
                    "上半年",
                    "牛熊榜"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药股“霸屏” A股上半年牛熊榜放榜",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]